Update on late-onset hypogonadism (LOH) or ADAM: diagnosis

Atualização em hipogonadismo masculino tardio (HMT) ou Daem: diagnóstico

1. The main signs and symptoms involved in late-onset male hypogonadism include the following, except:

1. Erectile dysfunction and decreased libido.

2. Anxiety.

3. Depression.

4. Decreased testicular volume.

2. On the main instruments used in the definition and diagnostic assessment of male aging, we cannot affirm that:

1. When analyzing the responses to the ADAM questionnaire, clinically suspected cases of LOH are those in which the symptoms of sexual dysfunction are present.

2. The Smith questionnaire is considered a questionnaire to assess the risk of LOH.

3. It is recommendable for the AMS scale and ADAM questionnaire to be used as screening instruments.

4. The use of the three instruments makes the diagnosis of HMT through functional and biochemical criteria unnecessary.

3. What is the role of the serum and free testosterone (BAT) levels in the diagnosis of late-onset hypogonadism?

1. Free testosterone is a less precise marker of hypogonadism.

2. The result of the total testosterone level does not affect the determination of free testosterone.

3. TT (total testosterone) would not be the ideal measure to assess late-onset hypogonadism.

4. There is a fall in testosterone and BAT levels at 2.3%/year and 1.1%/year.

4. Tests to be requested before the start of hormone replacement therapy (ART) include the following, except:

1. Baseline testosterone measurement.

2. Lipid evaluation.

3. Baseline PSA levels.

4. Evaluation of renal function.

5. How should prostate cancer be monitored?

1. Ultrasound-guided prostate biopsy.

2. PSA higher than 4 ng/mL or 3 ng/mL in men with a high risk of prostate cancer.

3. An increase in PSA levels higher than 1.4 ng/mL in any 12 month period during treatment.

4. Detection of prostatic abnormality during rectal examination.

Publication Dates

• Publication in this collection
  Sep-Oct 2014